Literature DB >> 31944695

Stilbenes with Potent Protein Tyrosine Phosphatase-1B Inhibitory Activity from the Roots of Polygonum multiflorum.

Thi-Thuy An Nguyen1, Manh Tuan Ha2, Se-Eun Park3, Jae Sue Choi3, Byung Sun Min2, Jeong Ah Kim1.   

Abstract

Seven new stilbene glycosides including three dimers (1-3) and four monomers (4-7) were isolated from the roots of Polygonum multiflorum along with nine previously identified stilbenes (8-16). In addition, two deglucosylated stilbenes, 2a and 3a, were also obtained as new dimeric stilbenes. The structures of the purified phytochemicals were elucidated by interpreting their spectroscopic data (NMR, HRMS, and ECD). To the best of our knowledge, this represents the first isolation of a phenylpropanoid (C6-C3) substituted with a stilbene unit (7) from the Polygonaceae family. In an in vitro enzyme assay with human recombinant protein tyrosine phosphatase-1B (PTP1B), compounds 2-5 showed weak PTP1B inhibition with an IC50 value range of 27.4-37.6 μM, while three deglucosylated stilbenes 2a, 3a, and 8a exhibited IC50 values of 2.1, 1.9, and 12.1 μM, respectively. The inhibition modes and binding mechanism of selected inhibitors (2a and 3a) were investigated using kinetic methods and molecular docking simulations.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31944695     DOI: 10.1021/acs.jnatprod.9b00777

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  In Vitro and in Silico Analysis of Phytochemicals From Fallopia dentatoalata as Dual Functional Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease.

Authors:  Yichuang Wu; Xiangdong Su; Jielang Lu; Meifang Wu; Seo Young Yang; Yang Mai; Wenbin Deng; Yongbo Xue
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

2.  Inhibition of PTP1B by farnesylated 2-arylbenzofurans isolated from Morus alba root bark: unraveling the mechanism of inhibition based on in vitro and in silico studies.

Authors:  Manh Tuan Ha; Srijan Shrestha; Thu Huong Tran; Jeong Ah Kim; Mi Hee Woo; Jae Sue Choi; Byung Sun Min
Journal:  Arch Pharm Res       Date:  2020-09-25       Impact factor: 4.946

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.